Inventor · disambiguated record
Zhonghao Liu
Also filed as: LIU ZHONGHAO
10 granted patents·4 pending applications·17 citations·filing 2015–2023
85Inventor score
Files withNGM BIOPHARMACEUTICALS INC14
Top patents by PatentIndex Score
14 records- 0191US10961315B2Method of treating type I diabetes by administering a combination of a glucagon receptor antagonist and an anti-CD3 antibodyNGM BIOPHARMACEUTICALS INC·Filed 2019·Granted Mar 30, 2021·5 cites·31 claims
- 0288US11136381B2Anti-C3 antibodiesNGM BIOPHARMACEUTICALS INC·Filed 2019·Granted Oct 5, 2021·3 cites·44 claims
- 0386US10995145B2Antibodies which bind human glucagon receptorNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted May 4, 2021·2 cites·29 claims
- 0485US10071139B2Methods for treatment of conditions associated with elevated triglycerides with an ANGPTL8 polypeptide fragmentNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Sep 11, 2018·3 cites·20 claims
- 0580US10774139B2ANGPTL8-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Sep 15, 2020·3 cites·49 claims
- 0678US10702587B2Angiopoietin-like protein 8 polypeptide fragments and compositions thereofNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Jul 7, 2020·1 cites·23 claims
- 0778US2024084023A1Glucagon receptor binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0876US2023382985A1C3-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0973US11767359B2C3-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2021·Granted Sep 26, 2023·0 cites·19 claims
- 1073US11732049B2Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptorNGM BIOPHARMACEUTICALS INC·Filed 2021·Granted Aug 22, 2023·0 cites·24 claims
- 1167US11845802B2Combination therapy with a glucagon receptor (GCGR) antibody and an anti-CD3 antibodyNGM BIOPHARMACEUTICALS INC·Filed 2021·Granted Dec 19, 2023·0 cites·23 claims
- 1260US11566067B2Methods of lowering triglyceride levels with an ANGPTL8-binding antibody or antigen-binding fragment thereofNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Jan 31, 2023·0 cites·38 claims
- 1359US2022251241A1Htra1-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1459US2021015902A1Angiopoietin-like protein 8 polypeptide fragments and compositions thereofNGM BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhonghao Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →